蘑菇视频APP

Companies are increasingly recognizing that diversity drives resilience, innovation, and success. This panel features Frances Arnold, Nobel Laureate, Generate:Biomedicines board member, and Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at the California Institute of Technology; Sue Desmond-Hellmann, former CEO of the Bill and Melinda Gates Foundation; Cynthia Patton, General Counsel and Secretary of Tessera Therapeutics; and 蘑菇视频APP Senior Partner Justine Levin-Allerhand, reflecting on their own experiences and where they see opportunities for impact through board engagement. More from Flagship @ JPM2024 here.